Detalles de la búsqueda
1.
Oral Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users.
Pain Med
; 18(7): 1278-1291, 2017 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27651514
2.
Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users.
Pain Med
; 17(5): 820-31, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26814240
3.
Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.
Clin J Pain
; 23(4): 287-99, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17449988
4.
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.
JAMA
; 296(1): 87-93, 2006 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-16820551
5.
Pharmacokinetic Profile and Sustained 24-hour Analgesia of a Once-daily Hydrocodone Bitartrate Extended-release Tablet with Abuse-deterrent Properties.
Clin Ther
; 38(2): 302-14, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26749219
6.
Abuse potential of intravenous oxycodone/naloxone solution in nondependent recreational drug users.
Clin Drug Investig
; 34(6): 421-9, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24756361
7.
Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users.
J Clin Pharmacol
; 54(4): 468-77, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24243216
8.
Attractiveness of reformulated OxyContin(R) tablets: assessing comparative preferences and tampering potential.
J Psychopharmacol
; 27(9): 808-16, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23784739
9.
Pharmacokinetics, tolerability, and safety of intranasal administration of reformulated OxyContin(®) tablets compared with original OxyContin (®) tablets in healthy adults.
Clin Drug Investig
; 33(6): 441-9, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23677743
10.
Once-weekly transdermal buprenorphine application results in sustained and consistent steady-state plasma levels.
J Pain Symptom Manage
; 46(1): 65-75, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23026548
11.
Effect of ketoconazole on the pharmacokinetic profile of buprenorphine following administration of a once-weekly buprenorphine transdermal system.
Clin Drug Investig
; 32(9): 583-92, 2012 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22845044
Resultados
1 -
11
de 11
1
Próxima >
>>